NASDAQ:EVFM

Evofem Biosciences Stock Insider Trading

etoro logo Buy EVFM
*Your capital is at risk
$0.0070
-0.0001 (-1.41%)
At Close: Jul 31, 2026

Evofem Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 8.22M and sold 1.75M EVFM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 8.22M shares
Sell 1.75M shares
76% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 10, 2021
Buy
Common Stock
P-Purchase
File Justin J.
Chief Financial Officer
C-Suite Officer 24 500
Value: $25.2K
May 20, 2021
Sell
Common Stock
F-InKind
Fitzpatrick Alexander A
General Counsel And Secretary
Officer 42 120
Value: $36.2K
May 20, 2021
Sell
Common Stock
F-InKind
Barrans Russell
Chief Commercial Officer
Officer 31 480
Value: $27.1K
May 20, 2021
Sell
Common Stock
F-InKind
Culwell Kelly
Chief Medical Officer
Officer 42 061
Value: $36.2K
May 20, 2021
Sell
Common Stock
F-InKind
File Justin J.
Chief Financial Officer
C-Suite Officer 42 280
Value: $36.4K
May 20, 2021
Sell
Common Stock
F-InKind
Pelletier Saundra L
Chief Executive Officer
CEO / President 105 300
Value: $90.6K
May 20, 2021
Sell
Common Stock
F-InKind
Pelletier Saundra L
Chief Executive Officer
CEO / President 105 300
Value: $90.6K
May 20, 2021
Sell
Common Stock
F-InKind
File Justin J.
Chief Financial Officer
C-Suite Officer 42 280
Value: $36.4K
May 20, 2021
Sell
Common Stock
F-InKind
Culwell Kelly
Chief Medical Officer
Officer 42 061
Value: $36.2K
May 20, 2021
Sell
Common Stock
F-InKind
Barrans Russell
Chief Commercial Officer
Officer 31 480
Value: $27.1K
May 20, 2021
Sell
Common Stock
F-InKind
Fitzpatrick Alexander A
General Counsel And Secretary
Officer 42 120
Value: $36.2K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Greer Gillian
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Rutherford Colin
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Rarick Lisa Dale
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Kamdar Kim P.
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Common Stock
A-Award
O'brien Anthony Stephen
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Hall William Walmsley
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Hall William Walmsley
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Common Stock
A-Award
O'brien Anthony Stephen
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Kamdar Kim P.
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Rarick Lisa Dale
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Rutherford Colin
Director
Director 90 000
Value: $112.5K
May 12, 2021
Buy
Stock option (right to buy)
A-Award
Greer Gillian
Director
Director 90 000
Value: $112.5K
Mar 09, 2021
Buy
Common Stock
P-Purchase
Pelletier Saundra L
Chief Executive Officer
CEO / President 45 249
Value: $103.2K
Mar 09, 2021
Buy
Common Stock
P-Purchase
Pelletier Saundra L
Chief Executive Officer
CEO / President 45 249
Value: $103.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT EVOFEM BIOSCIENCES INC.
Evofem Biosciences
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infectio...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE